Cita APA

Álvarez Larrán, A., Pereira Saavedra, A., Guglielmelli, P., Hernández Boluda, J. C., Arellano Rodrigo, E., Ferrer Marín, F., . . . Besses, C. (2016). Antiplatelet therapy versus observation in low-risk essential thrombocythemia with CALR mutation.

Citación estilo Chicago

Álvarez Larrán, Alberto, et al. Antiplatelet Therapy Versus Observation in Low-risk Essential Thrombocythemia With CALR Mutation. 2016.

Cita MLA

Álvarez Larrán, Alberto, et al. Antiplatelet Therapy Versus Observation in Low-risk Essential Thrombocythemia With CALR Mutation. 2016.